Autologous fat grafting offers hope for patients with alopecia, especially those with scarring, by reducing inflammation and stimulating hair growth. Patients with alopecia are either diagnosed with ...

The MHRA has approved deuruxolitinib, marketed as Leqselvi, for the treatment of severe alopecia areata in adults, offering a new therapeutic option for people living with the autoimmune condition.

Add Yahoo as a preferred source to see more of our stories on Google. From left to right: Madeline Lee, 13 with her her older sister Alison Lee, 17. Alison Lee felt a slight tug at the back of her ...

UK MHRA approves Sun Pharma’s deuruxolitinib to treat severe alopecia areata in adults: United Kingdom Friday, March 13, 2026, 09:00 Hrs [IST] The Medicines and Healthcare produ ...

Kristen Whitney, DO, FAAD, dermatologist at Allegheny Health Network, highlighted recent breakthroughs in treating alopecia areata, focusing on the effectiveness of Janus kinase inhibitors and the ...

Alopecia refers to hair loss and can affect the scalp, eyebrows, eyelashes, and other areas of the body. There are different types of alopecia including androgenetic alopecia, alopecia areata, anagen ...

Autoimmune disease hair loss can happen with alopecia areata, lupus, thyroid diseases, rheumatoid arthritis, Crohn’s disease, and scalp psoriasis. Each disease has different effects, ...

A national survey found broad consensus among hair experts on the use of intralesional corticosteroid (ILC) injections for alopecia but highlighted inconsistencies in dosing and injection parameters.

Alopecia areata is a nonscarring hair-loss condition that often has a patchy distribution and can be quite unpredictable. Alopecia areata is believed to be an autoimmune disease [1] involving T ...

If you’re reading this because you’re losing your hair, you’re not alone — hair loss is a common issue affecting more than half of men by the time they’re in their forties. The most common type of ...

Q. What is expected CAGR of Chemotherapy-Induced Alopecia Treatment market? A. The global chemotherapy-induced alopecia (CIA) treatment market is expected to grow at a moderate CAGR of around 6.5% ...

It exceeded her hair-pectations ...